摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-O-[(N-phthalimido)prop-3-yl]-adenosine

中文名称
——
中文别名
——
英文名称
2'-O-[(N-phthalimido)prop-3-yl]-adenosine
英文别名
2'-O-[(N-phthalimido)prop-3-yl]adenosine;2-[1-[(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxypropyl]isoindole-1,3-dione
2'-O-[(N-phthalimido)prop-3-yl]-adenosine化学式
CAS
——
化学式
C21H22N6O6
mdl
——
分子量
454.442
InChiKey
WSSFCNJHGMCPPN-LMDXUXIUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    33
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    166
  • 氢给体数:
    3
  • 氢受体数:
    10

反应信息

  • 作为产物:
    参考文献:
    名称:
    2'-modified oligonucleotides
    摘要:
    提供了用于治疗和诊断易于调节选定蛋白质产生的疾病的组合物和方法。根据首选实施方式,提供了可以与RNA或DNA的选定序列特异杂交的寡核苷酸和寡核苷酸类似物,其中核苷酸单元中的至少一个2'-脱氧呋喃糖基被修改。提供了治疗由各种病毒和其他致病因子引起的疾病的方法。
    公开号:
    US05859221A1
点击查看最新优质反应信息

文献信息

  • 2'modified oligonucleotides
    申请人:ISIS Pharmaceuticals, Inc.
    公开号:US06531584B1
    公开(公告)日:2003-03-11
    Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2′-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
    提供了用于治疗和诊断对调节特定蛋白质产生敏感的疾病的组合物和方法。根据优选实施例,提供了可以特异性杂交于RNA或DNA的选定序列的寡核苷酸和寡核苷酸类似物,其中核苷酸单元的至少一个2'-脱氧呋喃糖苷基被修改。提供了治疗由各种病毒和其他致病因子引起的疾病的方法。
  • 2'-modified oligonucleotides
    申请人:ISIS Pharmaceuticals, Inc.
    公开号:US05859221A1
    公开(公告)日:1999-01-12
    Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2'-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
    提供了用于治疗和诊断易于调节选定蛋白质产生的疾病的组合物和方法。根据首选实施方式,提供了可以与RNA或DNA的选定序列特异杂交的寡核苷酸和寡核苷酸类似物,其中核苷酸单元中的至少一个2'-脱氧呋喃糖基被修改。提供了治疗由各种病毒和其他致病因子引起的疾病的方法。
  • 2' -modified oligonucleotides
    申请人:ISIS Pharmaceuticals, Inc.
    公开号:US20030187240A1
    公开(公告)日:2003-10-02
    Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2′-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
    提供了用于治疗和诊断可调节选择蛋白质生成的疾病的组合物和方法。根据优选实施例,提供了可以与RNA或DNA的选择序列特异性杂交的寡核苷酸和寡核苷酸类似物,其中核苷酸单元的至少一个2'-脱氧呋喃糖基团被修饰。提供了治疗由各种病毒和其他致病因子引起的疾病的方法。
  • 2'-MODIFIED OLIGONUCLEOTIDES
    申请人:Cook Dan Phillip
    公开号:US20080032945A1
    公开(公告)日:2008-02-07
    Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2′-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
    本发明提供了用于治疗和诊断对调节所选蛋白质产生敏感的疾病的组合物和方法。根据优选实施例,提供了可以与RNA或DNA的所选序列特异性杂交的寡核苷酸和寡核苷酸类似物,其中核苷酸单元的至少一个2'-脱氧呋喃糖基团被修改。提供了治疗由各种病毒和其他致病因子引起的疾病的方法。
  • 2'-Modified Oligonucleotides
    申请人:Cook Phillip Dan
    公开号:US20090198047A1
    公开(公告)日:2009-08-06
    Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2′-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
    本发明提供了用于治疗和诊断适于调节所选蛋白质产生的疾病的组合物和方法。根据优选实施例,提供了可以与RNA或DNA的选定序列特异性杂交的寡核苷酸和寡核苷酸类似物,其中核苷酸单元的至少一个2'-脱氧呋喃糖苷基团被修饰。提供了治疗由各种病毒和其他致病因子引起的疾病的方法。
查看更多